NCT00477425View on ClinicalTrials.gov

A Study to Evaluate Corrected QT Interval From Clinical Studies Conducted With Bevacizumab

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

June 30, 2007

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2007

Conditions
Carcinoma
Sponsors

Lead Sponsor

Genentech, Inc.
All Listed Sponsors
lead

Genentech, Inc.

INDUSTRY

NCT00477425 - A Study to Evaluate Corrected QT Interval From Clinical Studies Conducted With Bevacizumab | Biotech Hunter | Biotech Hunter